Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 16, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Prostate Cancer Treatment: Cryoablation in Context.

Thomas Lilieholm1, Michael C Risk2, David Jarrard2

  • 1Department of Medical Physics, University of Wisconsin-Madison, Madison, WI 53705, USA.

Cancers
|July 15, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Clinical Validation of a Protocol-Agnostic Machine Learning Platform for Automated Treatment Planning in External Beam Radiation Therapy.

Advances in radiation oncology·2026
Same author

Semen RNA-Based Biomarkers for Prostate Cancer Detection and Risk Stratification: A Prospective Multicenter Validation Study.

The Journal of urology·2026
Same author

Androgen deprivation, androgen receptor-targeted vaccination, and nivolumab in patients with high-risk localized prostate cancer.

Journal for immunotherapy of cancer·2026
Same author

Percutaneous Microwave Ablation Preserves Renal Function with Similar Long Term Oncologic Outcomes Compared to Surgery for Clinical T1 Renal Cell Carcinoma.

Cancers·2026
Same author

Response to comment by Semwal et al.

BJU international·2026
Same author

Impact of commonly used medications on the detection of clinically significant prostate cancer in the targeted biopsy era.

American journal of clinical and experimental urology·2025

Focal cryoablation is an effective and well-tolerated treatment for prostate cancer (PCa), offering a minimally invasive option for primary and recurrent cases. Further long-term studies are needed to fully establish its benefits and standardize outcomes.

Area of Science:

  • Oncology
  • Urology
  • Minimally Invasive Surgery

Background:

  • Prostate cancer (PCa) is a common malignancy in men, with current research focusing on treatments that improve quality of life.
  • Focal cryoablation is emerging as a promising treatment due to its reduced morbidity and potential for salvage therapy.

Purpose of the Study:

  • To discuss the safety and efficacy of focal cryoablation for prostate cancer.
  • To contextualize focal cryoablation within existing treatment modalities.

Main Methods:

  • A review and collation of publications on prostate cancer cryoablation.
  • Comparative analysis against radiation, surgery, hormone therapy, and other ablation techniques.

Main Results:

Keywords:
CTMRIcryoablationfocal therapyprostatesalvage therapyultrasoundurology

More Related Videos

Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

Related Experiment Videos

Last Updated: Jul 16, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

Focal Laser Ablation of Prostate Cancer: An Office Procedure
11:07

Focal Laser Ablation of Prostate Cancer: An Office Procedure

Published on: March 30, 2021

  • Prostate cryoablation is characterized as effective and well-tolerated for primary and recurrent PCa.
  • Current data are limited by heterogeneous evidence, lack of standardized endpoints, and few randomized trials.

    • Conclusions:

    • Focal cryoablation is an evolving, minimally invasive option for prostate cancer patients.
    • Additional long-term studies are necessary to validate its efficacy and standardize its application.